A nanocomplex system as targeted contrast agent delivery vehicle for magnetic resonance imaging dynamic contrast enhancement study

Journal of Nanoscience and Nanotechnology

Volumn 10, Issue 11, 2010, Pages 7545-7549

  Korotcov, Alexandru ^a   Shan, Liang ^a   Meng, Huan ^b   Wang, Tongxin ^a   Sridhar, Rajagopalan ^a   Zhao, Yuliang ^b   Liang, Xing Jie ^c   Wang, Paul C ^a  

^a HOWARD UNIVERSITY   (United States)

^b INSTITUTE OF HIGH ENERGY PHYSICS   (China)

^c NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

Author keywords

Cancer; Dynamic contrast enhancement (DCE) MRI; Liposome; Nanoparticle; Targeted drug delivery; Transferrin

Indexed keywords

CANCER; CANCER PROGNOSIS; DELIVERY VEHICLE; DYNAMIC CONTRAST ENHANCEMENT; DYNAMIC CONTRAST ENHANCEMENT (DCE)-MRI; GD-DTPA; IMAGE CONTRASTS; IN-VIVO; MRI CONTRAST AGENTS; MRI IMAGE; NANOCOMPLEXES; NON-INVASIVE MONITORING; PROSTATE CANCERS; TARGETED CONTRAST AGENTS; TARGETED DRUG DELIVERY; TRANSFERRIN; TUMOR-SPECIFIC TARGETING;

DISEASES; DRUG DELIVERY; GADOLINIUM; NANOPARTICLES; RESONANCE; SIGNAL SYSTEMS; TUMORS;

MAGNETIC RESONANCE IMAGING;

CONTRAST MEDIUM;

ANIMAL; ARTICLE; MOUSE; NANOTECHNOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING;

ANIMALS; CONTRAST MEDIA; MAGNETIC RESONANCE IMAGING; MICE; NANOTECHNOLOGY;

EID: 79952109921     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2010.2821     Document Type: Conference Paper

References (17)

1. A. Jackson, D. Buckley, and G. J. M. Parker, Dynamic Contrast- Enhanced Magnetic Resonance Imaging in Oncology, Springer, Berlin Heidelberg (2005).
2. T. E. Yankeelov and J. C. Gore, Curr Med. Imaging Rev. 3, 91 (2009).
3. M. Aref, A. R. Chaudhari, K. L. Bailey, S. Aref, and E. C. Wiener, Magn. Reson. Imaging 26, 1279 (2008).
4. K. Glunde, M. A. Jacobs, A. P. Pathak, D. Artemov, and Z. M. Bhujwalla, NMR Biomed. 22, 92 (2009).
5. R. Alonzi, A. R. Padhani, and C. Allen, Eur. J. Radiol. 63, 335 (2007).
6. J. S. Taylor and W. E. Reddick, Adv. Drug Deliv. Rev. 41, 91 (2000).
7. M. Tozaki, Magn. Reson. Med. Sci. 3, 189 (2004).
8. X. C. Weibo Cai, Small 3, 1840 (2007).
9. V. P. Torchilin, Adv. Drug Deliv. Rev. 58, 1532 (2006).
10. T. R. Daniels, T. Delgado, J. A. Rodriguez, G. Helguera, and M. L. Penichet, Clin. Immunol. 121, 144 (2006).
11. Z. M. Qian, H. Li, H. Sun, and K. Ho, Pharmacol. Rev. 54, 561 (2002).
12. D. Hogemann-Savellano, E. Bos, C. Blondet, F Sato, T. Abe, L. Josephson, R. Weissleder, J. Gaudet, D. Sgroi, P. J. Peters, and J. P. Basilion, Neoplasia 5, 495 (2003).
13. T. R. Daniels, T. Delgado, G. Helguera, and M. L. Penichet, Clin. Immunol. 121, 159 (2006).
14. X. Li, L. Ding, Y. Xu, Y. Wang, and Q. Ping, Int. J. Pharm. 373, 116 (2009).
15. L. Shan, S. Wang, R. Sridhar, Z. M. Bhujwalla, and P. C. Wang, Mol. Imaging 6, 85 (2007).
16. L. Xu, K. F. Pirollo, W.-H. Tang, A. Rait, and E. H. Chang, Hum. Gene Ther 10, 2941 (1999).
17. S. Ghosh, A. Mukherjee, P. J. Sadler, and S. Verma, Angew. Chem., Int. Ed. 47, 2217 (2008).